About 1 result found for searched term "AS1810722" (0.221 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21381 | AS1810722 | STAT |
| AS1810722 is an orally effective STAT6 inhibitor with an IC50 of 1.9 nM. AS1810722 shows good CYP3A4 inhibition and is a thickened bicyclic pyrimidine derivative with potential for use in allergic disease studies, such as asthma and atopic diseases. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
